June 7-8, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
Targeted protein degradation plays a critical role in regulating nearly all cellular functions, and as such, its dysfunction is associated with severe pathologies including diseases like cancer, neurodegeneration and age-associated diseases. Therefore, fundamental insights into protein clearance pathways might be harnessed for therapeutic applications against a wide range of diseases. While much progress has been made in revealing mechanisms of autophagy and the ubiquitin-proteasome system, the major protein degradation pathways defined thus far, these fields continue to remain isolated from each other despite the interconnection of these processes. This separation is now leading to an urgent need to discuss the interplay of these pathways at the molecular and cellular levels to integrate our understanding of these processes and how they contribute to disease pathology. This conference will bring together researchers from these different fields, who do not typically interact, to build a holistic and integrated vision of protein degradation. Such an integrative conference highlighting the connections between the different branches of protein degradation research does not yet exist, so this Keystone Symposia conference will be the first of its kind to reshape how these fields interact and collaborate to yield transformative insights into both basic science and disease processes.
Topics of discussion will include:
Attendees will be exposed to novel perspectives, as well as methods, techniques and approaches, that will advance research within their field, and across the many different components in the protein degradation landscape.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed
*Abstract submission is required in order to submit an ePoster and/or Scitalk
#VKSPDegradation21
Speaking at this eSymposia
Eric J. Bennett
University of California, San Diego, USA
Carolyn R. Bertozzi
Stanford University, USA
Tim Clausen
Research Institute of Molecular Pathology, IMP, Austria
Della David
Eberhard Karls Universität Tübingen, Germanyy
Raymond J. Deshaies
Amgen, Inc., USA
Ivan Dikic
Goethe University Medical School, Germany
Daniel J. Finley
Harvard University, USA
Judith Frydman
Stanford University, USA
Jonathan Goodwin
Casma Therapeutics, USA
Malene Hansen
Sanford Burnham Prebys Medical Discovery Institute, USA
J. Wade Harper
Harvard Medical School, USA
Ursula Jakob
University of Michigan, USA
Sascha Martens
University of Vienna, Austria
Brenda A. Schulman
Max Planck Institute of Biochemistry, Germany
Michal Sharon
Weizmann Institute of Science, Israel
Anne Simonsen
University of Oslo, Norway
Nicolas H. Thomä
Friedrich Miescher Institute for Biomedical Research, Switzerland
Kylie J. Walters
NCI, National Institutes of Health, USA
Eilika Weber-Ban
ETH Zürich, Switzerland
Ingrid E. Wertz
Genentech, Inc., USA
Hong Zhang
Chinese Academy of Sciences, China
Funding for this conference was made possible (in part) by 1R13TR003730-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
